TSLP and primary cutaneous T-cell non-Hodgkin lymphoma: While a role of TSLP in inducing a Th2 microenvironment in CTCL and possibly promoting the proliferation of malignant T cells is recognized, clinical evidence supporting the therapeutic targeting of this cytokine is missing.